Market Segmentation
- U.S. Infection Imaging Services Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Fever of unknown origin
- Nuclear medicine
- Others
- Orthopedic Hardware
- Nuclear medicine
- Others
- Musculoskeletal infection
- Nuclear medicine
- Others
- Acute Appendicitis
- Nuclear medicine
- Others
- Osteomyelitis
- Nuclear medicine
- Others
- Systemic vasculitis
- Nuclear medicine
- Others
- Skin and soft tissue infection
- Nuclear medicine
- Others
- Cardiovascular inflammation
- Nuclear medicine
- Others
- Pneumonia
- Nuclear medicine
- Others
- Tuberculosis
- Nuclear medicine
- Others
- Endocarditis
- Nuclear medicine
- Others
- Myocarditis
- Nuclear medicine
- Others
- LVAD infection
- Nuclear medicine
- Others
- Crohn’s Disease
- Nuclear medicine
- Others
- Colitis
- Nuclear medicine
- Others
- Atherosclerosis
- Nuclear medicine
- Others
- Coronary artery disease
- Nuclear medicine
- Others
- Organ transplant rejection
- Nuclear medicine
- Others
- Others
- Nuclear medicine
- Others
- Fever of unknown origin
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
